Stratec SE (ETR:SBS)

Market Cap	322.74M
Revenue (ttm)	257.62M
Net Income (ttm)	16.02M
Shares Out	12.16M
EPS (ttm)	1.32
PE Ratio	20.14
Forward PE	14.27
Dividend	0.60 (2.23%)
Ex-Dividend Date	Jun 30, 2025

Volume	6,295
Average Volume	12,345
Open	26.65
Previous Close	26.85
Day's Range	26.25 - 26.90
52-Week Range	21.00 - 48.55
Beta	0.49
RSI	52.12
Earnings Date	May 30, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2018
• Employees: 1,387
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SBS

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.